放射性胶体示踪剂解剖定位影响前列腺癌前哨淋巴结手术结局
结果显示示踪剂在前列腺内的沉积位置影响淋巴引流模式及肿瘤阳性前哨淋巴结的显示,提示将示踪剂注射于原发肿瘤附近或瘤内有利于识别转移。
要点
- 示踪剂在前列腺右侧或左侧沉积与身体同侧淋巴引流明显相关。
- 背侧沉积较腹侧沉积显示更多淋巴结,基底部与尖部沉积引流模式不同。
- 瘤内沉积较瘤外沉积可能提高显示淋巴结转移的机会。
核心结论
- 示踪剂沉积位置与原发肿瘤位置及肿瘤阳性前哨淋巴结显示相关,提示示踪剂注射靠近或进入原发肿瘤部位有利于识别转移。
研究设计与样本
- 前列腺内注射ICG-99mTc-纳米胶体后,基于淋巴显像和SPECT/CT行前哨淋巴结定位,结合放射与荧光引导切除前哨淋巴结。
- 病理用于确定原发肿瘤位置和转移播散,石蜡包埋前列腺组织荧光成像用于确定示踪剂沉积位置。
主要发现
- 共识别265枚放射性淋巴结(211枚前哨淋巴结和54枚更高梯队淋巴结,来自64例患者;每例4.3枚,IQR:2-6)。
- 3例患者(4%)术前成像未能识别前哨淋巴结。
- 示踪剂在前列腺右侧或左侧沉积与身体同侧淋巴引流明显相关。
- 背侧示踪剂沉积较腹侧沉积显示更多淋巴结。
- 基底部或尖部示踪剂沉积观察到不同引流模式,且瘤内沉积较瘤外沉积可能提高显示淋巴结转移的机会。
临床怎么用
- 在前列腺癌前哨淋巴结手术中,应考虑将示踪剂注射于原发肿瘤附近或瘤内,以提高淋巴转移的识别准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Diagnostic imaging modalities have moderate sensitivity for the identification of lymph node (LN) metastases in prostate cancer (PCa) patients. Mapping the lymphatic drainage from the prostate can help to identify the LNs directly draining from the tumour (sentinel nodes (SNs)); the LNs stated to have the highest chance of containing metastatic cancer cells. Although the lymphatic drainage may differ between segments within the prostate, the location of the primary tumour is not routinely taken into account during peripheral zone-aimed tracer administration. This study evaluates whether linking the SN procedure to the primary cancer deposits increases the identification accuracy of lymphatic metastases. METHODS: Sixty-seven PCa patients, scheduled for robot-assisted laparoscopic prostatectomy (RALP) and extended lymph node dissection (ePLND) with subsequent SN biopsy, were included in this retrospective study. After injection of the hybrid tracer ICG-99mTc-nanocolloid in the prostate, SN mapping was performed based on lymphoscintigraphy and SPECT/CT. SNs were resected using a combination of radio- and fluorescence guidance. Pathology was used to determine the primary tumour location and metastatic spread. Fluorescence imaging of paraffin-embedded prostate tissue was used to determine the location of the tracer deposits in the prostate. This deposition was related to the primary tumour location, the lymphatic drainage pattern of the injected tracer, and the metastatic spread. RESULTS: In total 265 radioactive LNs (211 SNs and 54 higher-echelon nodes in 64 patients; 4.3 LNs per patient; IQR: 2-6) were identified. In three patients (4%) preoperative imaging did not allow identification of SNs. Tumour-positive SN visualization within the pelvis was shown to be influenced by intraprostatic location of tracer administration. This could be concluded from (1) a clear correlation between lymphatic drainage to the right or left side of the body and tracer deposition on the right or left side of the prostate, (2) visualization of a higher number of LNs after dorsal tracer deposition compared with ventral tracer deposition, (3) different drainage patterns observed for tracer deposition into the base or apex of the prostate, and (4) the indication that intratumoural tracer deposition increases the chance of visualizing nodal metastases compared with extratumoural tracer deposition. CONCLUSIONS: The correlation between the location of the tracer deposits, the location of the primary tumour, and the visualization of the (tumour-positive) SNs indicated that placement of tracer deposits is of influence on the visualized lymphatic drainage pattern. This suggests that tracer injection near or into the primary tumour site is beneficial for the identification of metastatic spread.
引用
- de Korne CM, Wit EM, de Jong J, et al. Anatomical localization of radiocolloid tracer deposition affects outcome of sentinel node procedures in prostate cancer. Eur J Nucl Med Mol Imaging. 2019. PMID: 31377820. doi:10.1007/s00259-019-04443-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。